Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 16;33(spe1):e2024342.
doi: 10.1590/S2237-96222024v33e2024342.especial.en. eCollection 2024.

Sociodemographic and clinical follow-up profile of transgender people accessing pre-exposure prophylaxis for the risk of HIV transmission in São Paulo, Brazil (2018-2021)

[Article in English, Portuguese]
Affiliations

Sociodemographic and clinical follow-up profile of transgender people accessing pre-exposure prophylaxis for the risk of HIV transmission in São Paulo, Brazil (2018-2021)

[Article in English, Portuguese]
Marcos Morais Santos Silva et al. Epidemiol Serv Saude. .

Abstract

Objective: To describe the sociodemographic and clinical follow-up profile of the use of pre-exposure prophylaxis (PrEP) of HIV among transgender people receiving care at a reference health service for sexually transmitted infections and HIV/AIDS in São Paulo, the capital city of São Paulo state, between 2018 and 2021.

Method: This was a descriptive study with an analysis of sociodemographic data, reasons for seeking PrEP , discontinuation of use and experiences of clinical follow-up. Descriptive statistics were used.

Results: Among the 53 individuals, the majority were mixed-race (n= 25), transgender women (n= 48), heterosexual (n= 38) and had more than 11 years of study (n= 22). There was a decrease in follow-up visits (n= 14 to n= 3) after the second medical consultation.

Conclusion: It is necessary to develop strategies to increase PrEP dispensing and continuation among transgender people, especially among Black people and those with lower level of education.

Main results: The majority of pre-exposure prophylaxis (PrEP) users were young, mixed-race, educated transgender women, reflecting a portion of the transgender population with access to healthcare. The discontinuation of clinical follow-up, especially after the second medical consultation, requires attention.

Implications for services: Individualized strategies should be prioritized to improve the dispensing of PrEP and clinical follow-up for both transgender men and transgender women.

Perspectives: Further research should focus on investigation of strategies to increase PrEP dispensing and clinical follow-up for transgender people, with an emphasis on transgender men, Black people and those with lower level of education.

Objetivo: Describir el perfil sociodemográfico y el seguimiento del uso de la profilaxis preexposición (PrEP) para el VIH entre las personas transexuales atendidas en un servicio de salud de referencia para infecciones de transmisión sexual y VIH/sida en la ciudad de São Paulo entre 2018 y 2021.

Método: Estudio descriptivo que analizó datos sociodemográficos, motivos de búsqueda de PrEP, interrupción del uso y experiencias de seguimiento clínico. Se utilizó estadística descriptiva.

Resultados: Entre las 53 personas, la mayoría eran morenas (n=25), mujeres trans (n=48), heterosexuales (n=38) y con más de 11 años de escolaridad (n=22). Hubo una disminución de las visitas de seguimiento (de n=14 a n=3) a partir de la segunda consulta.

Conclusión: Es necesario desarrollar estrategias para aumentar la dispensación y la continuidad del uso de la PPrE entre las personas trans, especialmente entre las personas de raza negra y con menor nivel de escolarización.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors declared no conflicts of interest.

References

    1. Buchbinder SP, Havlir DV. Getting to Zero San Francisco: A Collective Impact Approach. J Acquir Immune Defic Syndr. 2019;82(Suppl 3) - PMC - PubMed
    1. Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11) doi: 10.1016/S2352-3018(18)30215-7. - DOI - PubMed
    1. UNAIDS . Global HIV Prevention Coalition Scorecards: Key Findings. UNAIDS; Geneva: 2024.
    1. Powell VE, Gibas KM, DuBow J, Krakower DS. Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation. Curr Infect Dis Rep. 2019;21(8) doi: 10.1007/s11908-019-0685-6. - DOI - PMC - PubMed
    1. Ogunbajo A, Storholm ED, Ober AJ, Bogart LM, Reback CJ, Flynn R. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California. AIDS Behav. 2021;25 doi: 10.1007/s10461-021-03159-2. - DOI - PMC - PubMed

Substances